Dental Care Clinics in Roeland Park, KS Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Comfort Dental Roeland Park Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5201 Roe Blvd, Roeland Park, KS 66205 Phone: 913-828-0060 |
Celebrate Dental & Braces Dentist Medicare: Not Enrolled in Medicare Practice Location: 4980 Roe Blvd Ste A, Roeland Park, KS 66205 Phone: 913-355-0000 |
Partners In Care Dentistry, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5125 Roe Blvd Ste 100, Roeland Park, KS 66205 Phone: 913-831-4300 Fax: 913-831-6999 |
Comfort Dental Roeland Oark Dentist Medicare: Not Enrolled in Medicare Practice Location: 5201 Roe Blvd, Roeland Park, KS 66205 Phone: 913-828-0600 |
Celebraces Roeland Park Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 4980 Roe Blvd Ste A, Roeland Park, KS 66205 Phone: 913-355-0000 |
News Archive
Elekta's Versa HD system accelerates radiation delivery to new levels
Featuring a revolutionary combination of speed and accuracy, Elekta's new Versa HD system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to new levels.
Racial and ethnic minorities living in rural areas have greater risk for COVID-19 deaths
While Black, Hispanic, Latino, Indigenous, Asian and Pacific Islander people are more likely to die of COVID-19 than white people nationwide, a recent study from Oregon State University found the risk was even greater for racial and ethnic minority groups living in rural areas compared with urban areas.
Black women have greater estimated time to breast cancer surgery than whites
Less access to care and lower insurance coverage are among the reasons for racial disparities in breast cancer survival in the United States.
QCMG establishes Illumina technology as core sequencing platform
Illumina today announced that the Queensland Centre for Medical Genomics (QCMG), home of Australia's International Cancer Genomics Consortium program, has established Illumina technology as its core sequencing platform in an expanded facility.
Cetuximab and chemotherapy combination proves safe, effective for head and neck cancer patients
Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of cetuximab to chemotherapy, according to a University of Pittsburgh Cancer Institute (UPCI) phase II study. The results will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago as an oral presentation.
› Verified 6 days ago